These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 26662650

  • 21. Protective effect of zinc supplementation against cadmium-induced oxidative stress and the RANK/RANKL/OPG system imbalance in the bone tissue of rats.
    Brzóska MM, Rogalska J.
    Toxicol Appl Pharmacol; 2013 Oct 01; 272(1):208-20. PubMed ID: 23726800
    [Abstract] [Full Text] [Related]

  • 22. Serum osteoprotegrin (OPG) and receptor activator of nuclear factor kappaB (RANKL) in healthy children and adolescents.
    Wasilewska A, Rybi-Szuminska AA, Zoch-Zwierz W.
    J Pediatr Endocrinol Metab; 2009 Dec 01; 22(12):1099-104. PubMed ID: 20333868
    [Abstract] [Full Text] [Related]

  • 23. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
    Kim JG, Kim JH, Lee DO, Kim H, Kim JY, Suh CS, Kim SH, Choi YM.
    Menopause; 2008 Dec 01; 15(2):357-62. PubMed ID: 17925661
    [Abstract] [Full Text] [Related]

  • 24. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
    Baek KH, Oh KW, Lee WY, Tae HJ, Rhee EJ, Han JH, Cha BY, Kim YJ, Lee KW, Son HY, Kang SK, Kim CC, Kang MI.
    Bone; 2006 Dec 01; 39(6):1352-60. PubMed ID: 16905375
    [Abstract] [Full Text] [Related]

  • 25. [Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease].
    Xu DR, Su C, Zou WY, Xu HR, Huang S, Li J, Luo SK.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr 01; 18(2):376-80. PubMed ID: 20416172
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study.
    Weinbrenner T, Zittermann A, Gouni-Berthold I, Stehle P, Berthold HK.
    Eur J Clin Nutr; 2003 Oct 01; 57(10):1262-7. PubMed ID: 14506487
    [Abstract] [Full Text] [Related]

  • 28. Osteoprotegerin and RANKL serum levels and their relationship with serum ghrelin in children with chronic renal failure and on dialysis.
    Ozkaya O, Buyan N, Bideci A, Gonen S, Ortac E, Fidan K, Cinaz P, Söylemezoğlu O.
    Nephron Clin Pract; 2007 Oct 01; 105(4):c153-8. PubMed ID: 17259742
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Iron chelation therapy in Upper Egyptian transfusion-dependent pediatric homozygous beta-thalassemia major: impact on serum L-carnitine/free fatty acids, osteoprotegerin/the soluble receptor activator of nuclear factor-kappabeta ligand systems, and bone mineral density.
    Hamed EA, Mohamed NA, El-Metwally TH, Kamal MM.
    J Pediatr Hematol Oncol; 2010 May 01; 32(4):267-73. PubMed ID: 20445416
    [Abstract] [Full Text] [Related]

  • 31. Changes in serum RANKL and OPG with sexual development and their associations with bone turnover and bone mineral density in a cohort of girls.
    Lucas R, Ramos E, Prata M, Rodrigues AM, Costa L, Severo M, Canhão H, Fonseca JE, Barros H.
    Clin Biochem; 2014 Aug 01; 47(12):1040-6. PubMed ID: 24769277
    [Abstract] [Full Text] [Related]

  • 32. Associations between bone, fat tissue and metabolic control in children and adolescents with type 1 diabetes mellitus.
    Wędrychowicz A, Stec M, Sztefko K, Starzyk JB.
    Exp Clin Endocrinol Diabetes; 2014 Sep 01; 122(8):491-5. PubMed ID: 24918536
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
    Chiba Y, Onouchi T, Ikeda T, Adachi J, Tamura Y, Horiuchi T.
    Gerontology; 2009 Sep 01; 55(3):275-80. PubMed ID: 19158438
    [Abstract] [Full Text] [Related]

  • 37. Plasma levels of sRANKL and OPG are associated with atherogenic cytokines in patients with intermediate cardiovascular risk.
    Raaz-Schrauder D, Schrauder MG, Stumpf C, Lewczuk P, Kilian T, Dietel B, Garlichs CD, Schlundt C, Achenbach S, Klinghammer L.
    Heart Vessels; 2017 Nov 01; 32(11):1304-1313. PubMed ID: 28567553
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Weight gain reverses bone turnover and restores circadian variation of bone resorption in anorexic patients.
    Caillot-Augusseau A, Lafage-Proust MH, Margaillan P, Vergely N, Faure S, Paillet S, Lang F, Alexandre C, Estour B.
    Clin Endocrinol (Oxf); 2000 Jan 01; 52(1):113-21. PubMed ID: 10651762
    [Abstract] [Full Text] [Related]

  • 40. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression.
    Xie H, Xie PL, Wu XP, Chen SM, Zhou HD, Yuan LQ, Sheng ZF, Tang SY, Luo XH, Liao EY.
    Cardiovasc Res; 2011 Nov 01; 92(2):296-306. PubMed ID: 21750093
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.